ACADIA PHARMACEUTICALS INC revenue for the last year amounted to 658.16 M EUR, the most of which — 658.16 M EUR — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 483.28 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ACADIA PHARMACEUTICALS INC 658.16 M EUR, and the year before that — 483.28 M EUR.